AAD
  • Meeting Program
  • Registration
  • Daily Coverage
  • Photo Gallery
  • Samples & Solutions
Topics
  • Daily Coverage
  • Photo Gallery
  • Samples & Solutions
Resources
  • Meeting Program
  • Registration
Facebook iconInstagram iconTwitter X icon
Mar 10, 2024

Off label, on point

Spironolactone can be an effective treatment for patients with acne.


Headshot of Emmy Graber, MBA, MD, FAAD
Emmy Graber, MBA, MD, FAAD

Spironolactone is primarily used for the treatment of heart failure, high blood pressure, or hypokalemia — but more than a few dermatologists know that it can also be a secret weapon for treating acne in women.

Emmy Graber, MBA, MD, FAAD, founder and director of the Dermatology Institute of Boston, said that in spite of it being used for acne treatment for years, some dermatologists remain a little uncertain about using it today.

“It has FDA approval for other indications, but not for treating acne, and for that reason, some dermatologists are a little hesitant to use it for acne because it is an off-label use,” she said. 

The use of spironolactone was explored by Dr. Graber and other presenters, including Hilary Baldwin, MD, FAAD, Julie Claire Harper, MD, FAAD, and Bethanee Jean Schlosser, MD, PhD, FAAD, in Friday's session, F021 – Practical Guidelines for Using Spironolactone in Acne Patients.

Pinpointing the patient

One of the keys to effectively using the drug, Dr. Graber explained, is knowing who will benefit the most. For example, she said spironolactone is primarily used in women because of its potential side effects (such as gynecomastia) in men. But there are other factors to consider in deciding who is — and isn’t — a good candidate.

“You have to look at the age of the patient and when we might start treatment,” Dr. Graber said. “It also depends on what type of acne they have. We used to think that patients who were good candidates had primarily lower face or jawline acne, but that’s not necessarily the case anymore.”

Dr. Graber said dermatologists also must know when it is appropriate to do a lab workup in patients who may benefit from spironolactone treatment.

“Do we think that everyone whose acne flares up around the time of the menstrual cycle needs a hormonal (lab) workup for that acne?” she asked. “Probably not, but there are some telltale signs to look for, such as hirsutism, a deepening of the voice, and irregular periods, which may warrant a laboratory workup.”

Consider the side effects

As with any drug, there are potential side effects to consider with spironolactone, such as irregular menstrual cycles and the potential for hyperkalemia. 

Dr. Graber said there has long been concern over the possibility of breast cancer as well.

“Some physicians are leery of putting patients on spironolactone because of breast cancer concerns, but this is not supported by scientific studies,” she said.

Ultimately, Dr. Graber said it is up to dermatologists to decide if spironolactone is right for them and for their patients. But whether they use it or not, they should at least be aware of its potential and its benefits to the medical community.

“It is of particular interest to dermatologists because, although it is off-label, it can be a very successful treatment for acne,” she said. “In this era of antibiotic stewardship, we’re using antibiotics more selectively these days, so we want alternatives, and this is a non-antibiotic alternative that dermatologists should consider. It’s been proven to be an effective drug for treating acne.”  

Interesting Stories
DermWorld March | Publishing profiteers
Presented by AAD
DermWorld March | Publishing profiteers
DermWorld February | Glow Up
Presented by AAD
DermWorld February | Glow Up
DermWorld  January | Scar solutions
Presented by AAD
DermWorld January | Scar solutions
DermWorld May | Deciding the right time for treatment
Presented by AAD
DermWorld May | Deciding the right time for treatment
Dermworld June | Smoke and the skin
Presented by AAD
Dermworld June | Smoke and the skin
DermWorld April | Shedding light on treatments for female pattern hair loss
Presented by AAD
DermWorld April | Shedding light on treatments for female pattern hair loss
More in 2024 AAD Annual Meeting
Dsc01534
2024 AAD Annual Meeting
Stellar, inspiring, motivating, and mind-blowing!
Apr 12, 2024
Valerie Callender, MD, FAAD
2024 AAD Annual Meeting
Healing for all skin types
Apr 12, 2024
Posters Crowd2 Web
2024 AAD Annual Meeting
Poster awards announced!
Apr 12, 2024
A debate panel offered a look inside the challenges of caring for patients with medical dermatology disease.
2024 AAD Annual Meeting
Challenges, complexities, and dilemmas
Apr 12, 2024
Katharina Stephanie Shaw, MD, FAAD
2024 AAD Annual Meeting
Preparing for baby
Apr 12, 2024
Alexandra Flamm, MD, FAAD
2024 AAD Annual Meeting
Three elements of effective practice management
Apr 12, 2024
Marta J. Van Beek, MD, MPH, FAAD
2024 AAD Annual Meeting
A one-two punch for generalized pustular psoriasis (GPP)
Apr 12, 2024
Panelists present AAD session.
2024 AAD Annual Meeting
“Missed” diagnosis
Mar 18, 2024
Anisha Patel sits at table.
2024 AAD Annual Meeting
New cancer drugs can cause severe skin reactions
Mar 18, 2024
Professional headshot of Dr. Raj Chovatiya
2024 AAD Annual Meeting
A compendium of itch
Mar 18, 2024
Panel of four dermatologists presenting at AAD session.
2024 AAD Annual Meeting
Can we talk about it?
Mar 18, 2024
Robert Bissonnette delivers presentation at podium
2024 AAD Annual Meeting
From hands to feet
Mar 18, 2024
AAD
Facebook iconInstagram iconTwitter X icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.